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Purpose: Trauma-induced suppression of cellular immune function likely contributes to sepsis, multiple organ dysfunction 
syndrome and death. T cell proliferation decreases after traumatic stress. The addition of prostaglandin E2 (PGE2), which de-
presses immune function after hemorrhage and trauma, to T-cells decreases T-cell proliferation; and hypertonic saline re-
stores PGE2-induced T-cell suppression. Recently, it has become apparent that macrophage migration inhibitory factor (MIF) 
plays a central role in several immune responses, including T-cell proliferation. However, the role of MIF in mediating hyper-
tonic saline (HTS) restoration of T cell dysfunction is unknown. Therefore, we hypothesize that T cell immune restoration by 
HTS occurs, at least in part, by a MIF-mediated mechanism. Methods: Jurkat cells were cultured in Roswell Park Memorial 
Institute media, at a final concentration of 2.5 × 10
6 cell/mL. The effects of HTS on T-cell proliferation following PGE2-induced 
suppression were evaluated in Jurkat cells: HTS at 20 or 40 mmol/L above isotonicity was added. MIF levels were determined 
by enzyme-linked immunosorbent assay and western blot analysis. Results: PGE2 caused a 15.0% inhibition of Jurkat cell 
proliferation, as compared to the control. MIF levels decreased in PGE2-suppressed cells, as compared to the control. MIF lev-
els were higher in cells treated with HTS than PGE2-stimulated cells. Conclusion: The role of HTS in restoring Jurkat cells 
proliferation suppressed by PGE2, at least in part, should be mediated through a MIF pathway.
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INTRODUCTION
Immunological suppression is a well recognized con-
sequence of trauma and hemorrhagic shock, and contrib-
utes to infectious complications, ultimately leading to sep-
sis and multiple organ dysfunction syndrome (MODS) [1]. 
There are several mechanisms of post-traumatic immune 
impairment, including T cell dysfunction. T cell dysfunc-
tion after traumatic stress is characterized by a decrease in 
T cell proliferation. The addition of prostaglandin E2 
(PGE2), which depresses immune function after hemor-
rhage and trauma, to T cells decreases T-cell proliferation, 
while hypertonic saline (HTS) restores PGE2-induced 
T-cell suppression [2]. Young-Hoon Yoon, et al.
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Recently, it has become apparent that macrophage mi-
gration inhibitory factor (MIF) plays a central role in sev-
eral immune responses, including the modulation of sev-
eral cytokines and T-cell proliferation [3,4]. By controlling 
immune and inflammatory responses, MIF is thought to 
play an important role in the pathophysiology of septic 
shock and chronic inflammatory diseases [5-7]. The role of 
MIF mediating HTS restoration of T cell dysfunction is 
unknown. 
Therefore, we hypothesize, that T cell immune restora-
tion by HTS occurs, at least in part, by a MIF-mediated 
mechanism. The proposed experiments will provide the 
first evidence supporting MIF as the primary mechanism 
for restoring T cell dysfunction by HTS. 
METHODS
Cells culture and cell stimulation
Jurkat cells clone E6-1 (ATCC, Manassas, VA, USA) 
were maintained in Roswell Park Memorial Institute-1640 
(Invitrogen, Carlsbad, CA, USA) supplemented with 10% 
fetal bovine serum, 2 mM glutamine, 10 mM 4-(2-hydro-
xyethyl)-1-piperazineethanesulfonic acid (HEPES), 100 U/ 
mL penicillin/streptomycin at 37
oC in a 5% carbon dioxide 
incubator. Cells were cultured to a density of 5 × 10
5 cell/ 
mL. Cell viability, as determined by tyropan blue dye ex-
clusion, was ＞99%. For the protein extracts, cells were 
plated at a density of 2.5 × 10
6 cell/mL in a 6-well flat-bot-
tom culture plates, and were stimulated with PGE2 (1 
μg/mL) (Sigma-Aldrich Co., St. Louis, MO, USA) in the 
presence or absence of HTS at 20 mmol/L (HTS20) and 40 
mmol/L (HTS40) above isotonicity, resulting in sodium 
concentrations of 160 mmol/L and 180 mmol/L, which 
were measured by a GEM Premier 3000 (Instrumentation 
Laboratory, Lexington, MA, USA), respectively.
Protein extracts
After incubation for 24 hours at 37
oC, the cells were 
washed 2 times in cold phosphate buffered saline (PBS) 
and then centrifuged for 10 minutes. Cells pellet were re-
suspended in 10 μL per 2 × 10
6 cell/mL of superlysis buffer 
(protease inhibitors, 1 M HEPES, 5 M NaCl, 0.5 M ethyl-
enediaminetetraacetic acid, 1 mM NaOV4, 20% Triton 
X-100, 50 mM phenylmethylsulfonylfluoride), incubated 
on ice for 7 minutes, and then centrifuged at 3,000 × g for 15 
minutes at 4
oC. The supernatant was then transferred to an 
eppendorf tube and used for assay. The total protein con-
centration was determined by the Bradford method using 
a commercially available assay kit (Thermo Fisher Scien-
tific, Rockford, IL, USA) [8]. The prepared protein lysates 
were aliquoted and used for Western blot analysis.
T-cell proliferation assay
Jurkat cells were plated in 96-well flat-bottom tissue cul-
ture plates to attain a final concentration of 2.5 × 10
6 cell/ 
mL. 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-tetrazolium 
bromide (MTT) were conducted by the quantity of PGE2 
0.01, 0.1, 1, 10 μg/mL and MTT assay value was the lowest 
at PGE2 of 1 μg/mL (have not shown). Therefere, PGE2 1 
μg/ml were used. The effect of HTS on T-cell proliferation 
following PGE2-induced suppression was evaluated in 
Jurkat cells with 1 μg/mL PGE2, a concentration that sup-
presses T-cell proliferation, and HTS at 20 mmol/L and 40 
mmol/L above isotonicity was added at the same time as 
PGE2. After incubation for 24 hours at 37
oC, the resultant 
T-cell proliferation was determined by the MTT cell pro-
liferation assay (ATCC).
Enzyme-linked immunosorbent assay (ELISA) for 
MIF
MIF concentration in culture supernatants was meas-
ured by sandwich enzyme-linked immunosorbent assay. 
Briefly, 2 μg/mL of monoclonal capture antibody (R&D 
Systems, Minneapolis, MN, USA) was added to a 96-well 
plate and incubated for 2 hours at room temperature. After 
incubation, the plates were incubated in blocking solution 
comprised of PBS containing 1% bovine serum albumin 
(BSA) and 0.05% Tween 20 for 2 hours at room tempera-
ture. The test samples and standard recombinant MIF 
(R&D Systems) were added to the plates, and the plates 
were incubated for overnight at 4
oC. The plates were then 
washed four times with PBS containing Tween 20, 200 
ng/mL of biotinylated detection monoclonal antibodies 
(R&D Systems) was added, and the plates were incubated 
for 2 hours at room temperature. Subsequently, the plates Effect of HTS and MIF in restoration of T cell dysfunction
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Fig. 1. Prostaglandin E2 (PGE2) inhibited Jurkat cell proliferation by 
14.7% (P ＜ 0.05). The addition of HTS restored Jurkat cell 
proliferation suppressed by PGE2 to control levels, as measured by 
the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-tetrazolium bromide
(MTT) cell proliferation assay (P ＜ 0.05). There was no statistical 
difference in restoration by either HTS20 or HTS40. The experi-
ments were conducted 10 times and conducted by MTT. The 
experiments were also done by EZ-Cytox Cell viability assay kit 
(Daeil Lab, Seoul, Korea) and the results were the similar. ANOVA, 
analysis of variance. 
a)Mean ± SD (ANOVA, Paired t-test) P ＜  0.05, 
2.5 × 10
6 cell/mL 1 day incubation number: 10 times.
were washed, streptavidin-alkaline-phosphatase (1:2,000; 
Sigma-Aldrich Co.) was added, and the reaction was al-
lowed to proceed for 2 hours at room temperature. The 
plates were washed four times, and 1 mg/mL of p-nitro-
phenylphosphate dissolved in diethanolamine (Sigma- 
Aldrich Co.) was added to induce the color reaction, which 
was stopped by adding 50 μL of 1 N NaOH. The optical 
density at 405 nm was measured on an automated micro-
plate reader (Bio-Rad Laboratories Inc., Hercules, CA, 
USA). A standard curve was generated by plotting optical 
density versus the log of the MIF concentration. The ex-
periments were conducted 10 times.
Western blot analysis for MIF expression
Expression of MIF protein was quantified by Western 
blot analysis. Proteins (20 μg/sample) were fractionated on 
an 15% sodium dodecylsulfate-polyacrylamide gel (Bio- 
Rad Laboratories Inc.) and transferred onto a nitrocellu-
lose membrane. Membranes were blocked for 1 hour in 5% 
BSA (Sigma-Aldrich Co.), and then incubated with a pri-
mary antibody, anti-human MIF (1:250; R&D systems). 
After washing, membranes were incubated with 1:2000 
horseradish peroxidase-labeled goat anti-mouse antibody 
(R&D systems) as the secondary antibody. The proteins 
were detected using SuperSignal (Thermo Fisher Scientif-
ic Inc., Rockford, IL, USA) chemiluminescence kit.
Statistical analysis
One-way analysis of variance was performed to eval-
uate the significance of difference between the experi-
mental groups. For a single comparison of two groups, a 
Student’s t-test was used with SPSS ver. 12.0 (SPSS Inc., 
Chicago, IL, USA). Data are expressed as mean ± SD. 
Values of P ＜  0.05 were considered significant. All experi-
ments were performed in triplicate.
RESULTS
The effect of HTS on PGE2-induced Jurkat cell 
suppression 
Jurkat cells were plated on 96-well culture plates at a 
concentration of 2.5 × 10
6 cell/mL in cell culture media. 
PGE2 at 1 μg/mL inhibited Jurkat cell proliferation by 
14.7% (P ＜ 0.05) (Fig. 1). The addition of HTS restored 
Jurkat cell proliferation suppressed by PGE2 to control 
levels, as measured using an MTT cell proliferation assay 
(P ＜  0.05). There was no statistical difference in restora-
tion by either HTS20 or HTS40 (Fig. 1).
The effect of HTS on MIF concentrations in the 
cell supernatant
To determine the relation between HTS and MIF on 
Jurkat cell proliferation, MIF levels were measured in the 
cell supernatant. The MIF level was decreased by 0.98 
ng/mL ± 0.38 in the supernatant of PGE2 stimulated cells, 
when compared to control levels (1.19 ng/mL ± 0.48). On 
the other hand, HTS20 restored and increased the MIF lev-
el (1.09 ng/mL ± 0.38) in PGE2-suppressed Jurkat cells (P ＜ 
0.05). PGE2-suppressed Jurkat cells treated with HTS40 
had a higher MIF level (1.16 ng/mL ± 0.33) than HTS20- 
treated cells, however, there was not a statistically sig-
nificant difference of MIF levels in the supernatant of 
HTS20 or HTS40-treated cells (Fig. 2).Young-Hoon Yoon, et al.
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Fig. 3. Levels of migration inhibitory factor (MIF) protein 
expression were lower in prostaglandin E2 (PGE2)-stimulated cells 
( 1 6 %  d e c r e a s e  i n  b a n d  d e n s i t y )  ( P  ＜ 0.05). The addition of 
hypertonic saline (HTS) to PGE2-stimulated cells increased MIF 
protein expression with the highest expression in the HTS40- 
treated cells. ANOVA, analysis of variance. 
a)Mean ± SD (ANOVA, 
Paired t-test) P ＜  0.05, 2.5 × 10
6 cell/mL 1 day incubation MIF MW: 
12.5 KDa number: 5 times.
Fig. 2. Migration inhibitory factor (MIF) levels in cell supernatants 
were measured. Jurkat cells in presence of prostaglandin E2 (PGE2) 
had a decrease in MIF level (0.98 ng/mL ± 0.38), when compared 
with Jurkat cells alone (1.19 ng/mL ± 0.48). HTS20 restored and 
increased MIF level (1.09 ng/mL ± 0.38) when compared with 
PGE2-suppressed Jurkat cells (P ＜ 0.05). PGE2-suppressed Jurkat 
cells treated with HTS40 had the highest MIF level (1.16 ng/mL ±
0.33): however, there was no statistically significant difference in 
MIF levels between the HTS20- and HTS40-treated groups. The 
experiments were conducted 10 times. ANOVA, analysis of 
variance. 
a)Mean ± SD (ANOVA, Paired t-test) P ＜ 0.05, 2.5 × 10
6
cell/mL 1 day incubation number: 10 times.
The effect of HTS on MIF expression
To determine the HTS effect on MIF expression, western 
blot analysis was performed. Correlating with the ELISA, 
levels of MIF protein expression were lower in PGE2-sti-
mulating cells (16% decrease in band density) (P ＜  0.05). 
The addition of HTS to PGE2-stimulated cells increased 
MIF protein expression, with the highest expression in the 
HTS40-treated cells, however, there was not a statistically 
significant difference of MIF protein expression in the 
HTS20 or HTS40-treated cells (Fig. 3). 
DISCUSSION
Trauma-induced suppression of cellular immune func-
tion likely contributes to sepsis, MODS, and death. This 
suppression is secondary to several immunomodulating 
factors including PGE2, transforming growth factor beta 
(TGFβ), interleukin 4 (IL-4), and IL-10, which block certain 
intracellular signaling events in T-cells [1]. T-cell dysfunc-
tion after traumatic stress is characterized by a decrease in 
T-cell proliferation, an aberrant cytokine profile, de-
creased T-cell monocyte interactions, and attenuated ex-
pression of the T-cell Receptor Complex [9-11]. The exact 
mechanism involved in the development of T-cell dys-
function is unknown. Under stressful conditions, macro-
phage are triggered to rapidly produce and release PGE2, 
a powerful endogenous immune suppressant [12]. PGE2 
interacts with the corresponding membrane receptor of T 
cells, blocking T cell function by interfering with IL-2 gene 
expression at multiple stages [13-15]. In addition, PGE2 is 
a potent activator of cAMP-dependent protein kinase, 
which regulates expression of p27
kip1 and cyclin D3 to sup-
press proliferation of leukemic T cell lines, including 
Jurkat cells, by arresting cells in the G1 phase of the cell cy-
cle [15]. Therefore, the experiments were performed with 
PGE2, as it has been shown that PGE2, at a concentration of 
1 μg/mL, causes inhibition of T cell proliferation by about 
15%. Moreover, HTS restored suppressed PGE2-induced T 
cell proliferation. Hyperosmolality may play an important 
role in the HTS-enhancement of T-cell proliferation and 
hypertonicity increased IL-2 expression in T-cell pro-Effect of HTS and MIF in restoration of T cell dysfunction
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liferation [16-18]. However, the mechanism explaining the 
HTS-mediated restoration of T cell function is still unclear. 
MIF may serve as a general marker for systemic in-
flammation in septic and non-septic acute critical illness 
[5-7]. Furthermore, MIF is a cytokine that is secreted by the 
anterior pituitary and immune cells in response to surgical 
stress, injury, and sepsis. This cytokine appears to be a crit-
ical regulator of the inflammatory pathways, leading to 
systemic inflammatory response syndrome and sub-
sequent MOSF [4,19]. Besides, activated T cells produce 
MIF, and neutralizing anti-MIF antibodies inhibit T-cell 
proliferation and IL-2 production. T cells also release MIF 
in response to glucocorticoid stimulation and MIF acts to 
override glucocorticoid inhibition of T-cell proliferation, 
as well as interleukin 2 and interferon γ production [3]. 
And MIF also reduces pro-oxidative stress-induced apop-
tosis and nitric oxide induced apoptosis. As to a con-
tribution by MIF to the regulation of cell survival, the in-
hibitory effect of MIF on apoptosis could correlate with its 
reported stimulatory effects on cell proliferation, even 
though cellular apoptosis and cell proliferation do not 
simply oppose each other [20-22].
That is to say, MIF exhibits pro- and anti-inflammatory 
activities, and regulates cell proliferation and survival. 
Therefore, we know that T cell immune restoration by HTS 
occurs, at least in part, by a MIF-mediated mechanism. In 
our experiment, PGE2 inhibited Jurkat cell proliferation 
and decreased MIF levels, when compared to control 
levels. The addition of HTS increased MIF production, as 
compared with PGE2-stimulated Jurkat cells in con-
cordance with restored PGE2-suppressed Jurkat cell 
proliferation. Considering side effect of HTS, HTS at so-
dium concentrations of 160 mM showed sufficient result 
in this experiment. It has been suggested that HTS could 
be a proliferation regulator by a MIF-mediated mecha-
nism. In order words, PGE2 reduces expression of cyclin D 
and induces expression of p27
kip1, while MIF regulates the 
expression of the cell cycle regulators cyclin and p27 
[15,23,24]. Therefore, HTS could restore PGE2-suppressed 
Jurkat cell proliferation through MIF production. Cho et 
al. [25] showed that NF-kB inhibition leads to increased 
synthesis and secretion of MIF in human CD4+ T cells. 
Notably, HTS also inhibits NF-κB, as compared to isotonic 
saline, in our experiment (unpublished results). However, 
the mechanism of MIF regulation of HTS is not yet 
explained. 
Unfortunately, the present study is associated with cer-
tain limitation. First, PGE2 were used alone as immuno- 
suppressant in present study. If another immuno-sup-
pressant (IL-4, IL-10, et al.) were used, the present study 
might have more interesting outcome. Second, This study 
was done about MIF only, so other cytokine were not used. 
And ELISA and western blot analysis were performed for 
MIF levels. However, if another cytokine and another 
method for MIF levels (realtime PCR on the expression of 
mRNA for MIF) are used, the present study might have 
more interesting outcome, therefore, we will consider con-
ducting further experiments by using other cytokine and 
methods in the future. 
The role of HTS in restoring Jurkat cell proliferation 
suppressed by PGE2, at least in part, should be mediated 
through a MIF pathway. Further studies are needed to de-
termine the effects of HTS and MIF. 
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